https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.
Deaths involving COVID-19, pneumonia, and influenza reported to NCHS by sex, age group, and jurisdiction of occurrence.
Reporting of Aggregate Case and Death Count data was discontinued on May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. Although these data will continue to be publicly available, this dataset will no longer be updated.
The surveillance case definition for COVID-19, a nationally notifiable disease, was first described in a position statement from the Council for State and Territorial Epidemiologists, which was later revised. However, there is some variation in how jurisdictions implemented these case definitions. More information on how CDC collects COVID-19 case surveillance data can be found at FAQ: COVID-19 Data and Surveillance.
Aggregate Data Collection Process Since the beginning of the COVID-19 pandemic, data were reported from state and local health departments through a robust process with the following steps:
This process was collaborative, with CDC and jurisdictions working together to ensure the accuracy of COVID-19 case and death numbers. County counts provided the most up-to-date numbers on cases and deaths by report date. Throughout data collection, CDC retrospectively updated counts to correct known data quality issues.
Description This archived public use dataset focuses on the cumulative and weekly case and death rates per 100,000 persons within various sociodemographic factors across all states and their counties. All resulting data are expressed as rates calculated as the number of cases or deaths per 100,000 persons in counties meeting various classification criteria using the US Census Bureau Population Estimates Program (2019 Vintage).
Each county within jurisdictions is classified into multiple categories for each factor. All rates in this dataset are based on classification of counties by the characteristics of their population, not individual-level factors. This applies to each of the available factors observed in this dataset. Specific factors and their corresponding categories are detailed below.
Population-level factors Each unique population factor is detailed below. Please note that the “Classification” column describes each of the 12 factors in the dataset, including a data dictionary describing what each numeric digit means within each classification. The “Category” column uses numeric digits (2-6, depending on the factor) defined in the “Classification” column.
Metro vs. Non-Metro – “Metro_Rural” Metro vs. Non-Metro classification type is an aggregation of the 6 National Center for Health Statistics (NCHS) Urban-Rural classifications, where “Metro” counties include Large Central Metro, Large Fringe Metro, Medium Metro, and Small Metro areas and “Non-Metro” counties include Micropolitan and Non-Core (Rural) areas. 1 – Metro, including “Large Central Metro, Large Fringe Metro, Medium Metro, and Small Metro” areas 2 – Non-Metro, including “Micropolitan, and Non-Core” areas
Urban/rural - “NCHS_Class” Urban/rural classification type is based on the 2013 National Center for Health Statistics Urban-Rural Classification Scheme for Counties. Levels consist of:
1 Large Central Metro
2 Large Fringe Metro
3 Medium Metro
4 Small Metro
5 Micropolitan
6 Non-Core (Rural)
American Community Survey (ACS) data were used to classify counties based on their age, race/ethnicity, household size, poverty level, and health insurance status distributions. Cut points were generated by using tertiles and categorized as High, Moderate, and Low percentages. The classification “Percent non-Hispanic, Native Hawaiian/Pacific Islander” is only available for “Hawaii” due to low numbers in this category for other available locations. This limitation also applies to other race/ethnicity categories within certain jurisdictions, where 0 counties fall into the certain category. The cut points for each ACS category are further detailed below:
Age 65 - “Age65”
1 Low (0-24.4%) 2 Moderate (>24.4%-28.6%) 3 High (>28.6%)
Non-Hispanic, Asian - “NHAA”
1 Low (<=5.7%) 2 Moderate (>5.7%-17.4%) 3 High (>17.4%)
Non-Hispanic, American Indian/Alaskan Native - “NHIA”
1 Low (<=0.7%) 2 Moderate (>0.7%-30.1%) 3 High (>30.1%)
Non-Hispanic, Black - “NHBA”
1 Low (<=2.5%) 2 Moderate (>2.5%-37%) 3 High (>37%)
Hispanic - “HISP”
1 Low (<=18.3%) 2 Moderate (>18.3%-45.5%) 3 High (>45.5%)
Population in Poverty - “Pov”
1 Low (0-12.3%) 2 Moderate (>12.3%-17.3%) 3 High (>17.3%)
Population Uninsured- “Unins”
1 Low (0-7.1%) 2 Moderate (>7.1%-11.4%) 3 High (>11.4%)
Average Household Size - “HH”
1 Low (1-2.4) 2 Moderate (>2.4-2.6) 3 High (>2.6)
Community Vulnerability Index Value - “CCVI” COVID-19 Community Vulnerability Index (CCVI) scores are from Surgo Ventures, which range from 0 to 1, were generated based on tertiles and categorized as:
1 Low Vulnerability (0.0-0.4) 2 Moderate Vulnerability (0.4-0.6) 3 High Vulnerability (0.6-1.0)
Social Vulnerability Index Value – “SVI" Social Vulnerability Index (SVI) scores (vintage 2020), which also range from 0 to 1, are from CDC/ASTDR’s Geospatial Research, Analysis & Service Program. Cut points for CCVI and SVI scores were generated based on tertiles and categorized as:
1 Low Vulnerability (0-0.333) 2 Moderate Vulnerability (0.334-0.666) 3 High Vulnerability (0.667-1)
Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes
Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.
Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Age-standardised mortality rates (ASMRs) for deaths involving COVID-19 by ethnic group, England.
This dataset tracks the updates made on the dataset "Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose" as a repository for previous versions of the data and metadata.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Please see FAQ for latest information on COVID-19 Data Hub data flows: https://covid-19.geohive.ie/pages/helpfaqs.Notice:See the Technical Data Issues section in the FAQ for information about issues in data: https://covid-19.geohive.ie/pages/helpfaqs.Deaths: From 16th May 2022 onwards, reporting of Notified Deaths will be weekly (each Wednesday) with deaths notified since the previous Wednesday reported. This is based on the date on which a death was notified on CIDR, not the date on which the death occurred. Data on deaths by date of death is available on the new HPSC Epidemiology of COVID-19 Data Hub https://epi-covid-19-hpscireland.hub.arcgis.com/.Notice:
Please be advised that on 29th April 2021, the 'Aged65up' and 'HospitalisedAged65up' fields were removed from this table. The three fields 'Aged65to74', 'Aged75to84', and 'Aged85up' replace the 'Aged65up' field.The three fields 'HospitalisedAged65to74', 'HospitalisedAged75to84' and 'HospitalisedAged85up' replace the 'HospitalisedAged65up' field.Please be advised that on the week beginning 1st March 2021, the values in the following fields in this table were set to zero: 'CommunityTransmission' , 'CloseContact', 'TravelAbroad' and ‘ClustersNotified’. ----------------------------------------------------------------------This feature service contains the up to date Covid-19 Daily Statistics as well as the Profile of Covid-19 Daily Statistics for Ireland, as reported by the Health Protection Surveillance Centre.The Covid-19 Daily Statistics are updated once a week, each Wednesday, which includes data for the full time series. Data on deaths is updated once a week, each Wednesday, which includes data for the full time series.The further breakdown of these counts (age, gender, transmission, etc.) is part of a Daily Statistics Profile of Covid-19, to help identify patterns and trends.The primary Date applies to the following fields:ConfirmedCovidCases, TotalConfirmedCovidCases, ConfirmedCovidDeaths, TotalCovidDeaths, ConfirmedCovidRecovered,SevenDayAverageCases.The StatisticProfileDate applies to the following fields:CovidCasesConfirmed, HospitalisedCovidCases, RequiringICUCovidCases, HealthcareWorkersCovidCases,Clusters Notified,HospitalisedAged5,HospitalisedAged5to14,HospitalisedAged15to24,HospitalisedAged25to34,HospitalisedAged35to44,HospitalisedAged45to54,HospitalisedAged55to64,HospitalisedAged65to74,HospitalisedAged75to84,HospitalisedAged85up,Male, Female, Unknown,Aged1to4, Aged5to14, Aged15to24, Aged25to34, Aged35to44, Aged45to54, Aged55to64, Aged65to74,Aged75to84,Aged85up,MedianAgeCommunityTransmission, CloseContact, TravelAbroad, Total Deaths by Date of Death,Deaths by Date of Death.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
Note: Starting April 27, 2023 updates change from daily to weekly.
Summary The cumulative number of confirmed COVID-19 deaths among Maryland residents by age: 0-9; 10-19; 20-29; 30-39; 40-49; 50-59; 60-69; 70-79; 80+; Unknown.
Description The MD COVID-19 - Confirmed Deaths by Age Distribution data layer is a collection of the statewide confirmed COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by designated age ranges. A death is classified as confirmed if the person had a laboratory-confirmed positive COVID-19 test result. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Probable deaths are available from the MD COVID-19 - Probable Deaths by Age Distribution data layer.
Terms of Use The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Nursing homes with residents positive for COVID-19 from 4/22/2020 to 6/19/2020. Starting in July 2020, this dataset will no longer be updated and will be replaced by the CMS COVID-19 Nursing Home Dataset, available at the following link: https://data.ct.gov/Health-and-Human-Services/CMS-COVID-19-Nursing-Home-Dataset/w8wc-65i5. Methods: 1) Laboratory-confirmed case counts are based upon data reported via the FLIS web portal. Nursing homes were asked to provide cumulative totals of residents with laboratory confirmed covid. This includes residents currently in-house, in the hospital, or who are deceased. Residents were excluded if they tested positive prior to initial admission to the nursing home. 2) The cumulative number of deaths among nursing home residents is based upon data reported by the Office of the Chief Medical Examiner. For public health surveillance, COVID-19-associated deaths include persons who tested positive for COVID-19 around the time of death (laboratory-confirmed) and persons whose death certificate lists COVID-19 disease as a cause of death or a significant condition contributing to death (probable). Limitations: 1) As of the week of 5/10/20, Point Prevalence Survey testing is being offered to all asymptomatic nursing home residents to inform infection prevention efforts. Point prevalence surveys will be conducted over a period of several weeks. Some nursing homes had adequate testing resources available to conduct surveys prior to this date. Differences in survey timing will impact the number of positive results that a nursing home reports. 2) Cumulative totals of residents testing positive are being collected rather than individual resident data. Thus we cannot verify the counts, de-duplicate, and/or verify whether there is a record of a positive lab test. This may result in either under- or over-counting. 3) The number of COVID-19 positive residents and the number of confirmed deaths among residents are tabulated from different data sources. Due to the timing of availability of test results for deceased residents, it is not appropriate to calculate the percent of cases who died due to COVID-19 at any particular facility based upon this data. 4) The count of deaths reported for 4/14 are not included in this dataset, as they were not broken out by laboratory-confirmed or probable. They can be viewed in the DPH Report here: https://portal.ct.gov/-/media/Coronavirus/CTDPHCOVID19summary4162020.pdf?la=en
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
Note: Starting April 27, 2023 updates change from daily to weekly.
Summary The cumulative number of confirmed COVID-19 deaths among Maryland residents, by date of death.
Description The MD COVID-19 - Total Confirmed Deaths by Date of Death data layer is a collection of the statewide confirmed COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by date of death. A death is classified as confirmed if the person had a laboratory-confirmed positive COVID-19 test result. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Probable deaths are available from the MD COVID-19 - Total Probable Deaths by Date of Death data layer.
Terms of Use The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Public Health France’s mission is to improve and protect the health of populations. During the health crisis linked to the COVID-19 epidemic, Public Health France is responsible for monitoring and understanding the dynamics of the epidemic, anticipating the various scenarios and implementing actions to prevent and limit the transmission of this virus on the national territory. Description of the dataset This dataset describes the level of standardised excess mortality during the COVID-19 outbreak, at the departmental and regional level. The level of excess mortality is described for two age categories: — for all ages; — for persons over 65 years of age. Method of calculating levels The data are derived from the administrative part of the death certificate, collected by the civil registry offices of the municipalities having a dematerialised transmission with INSEE. The observed number of deaths is compared to an expected number, estimated from a statistical model established by the EuroMomo consortium and used by 24 countries or regions in Europe. The estimation of excess deaths is based on the calculation of a standardised indicator (Z-score), which makes it possible to compare excesses between different geographical levels or age groups. The Z-score is calculated by the formula: (observed number — expected number)/standard deviation of expected number. The five categories of excess are defined as follows: — No excess: standardised Death Indicator (Z-score) < 2 — Moderate excess of death: standardised Death Indicator (Z-score) between 2 and 4.99 — High excess of death: standardised Death Indicator (Z-score) between 5 and 6.99: — Very high excess of death: standardised Death Indicator (Z-score) between 7 and 11.99: Exceptional excess of standardised death indicator of death (Z-score) greater than 12 Limits of the calculation method
https://www.pioneerdatahub.co.uk/data/data-request-process/https://www.pioneerdatahub.co.uk/data/data-request-process/
PIONEER: The impact of ethnicity and multi-morbidity on COVID-related outcomes; a primary care supplemented hospitalised dataset Dataset number 3.0
Coronavirus disease 2019 (COVID-19) was identified in January 2020. Currently, there have been more than 65million cases and more than 1.5 million deaths worldwide. Some individuals experience severe manifestations of infection, including viral pneumonia, adult respiratory distress syndrome (ARDS) and death. Evidence suggests that older patients, those from some ethnic minority groups and those with multiple long-term health conditions have worse outcomes. This secondary care COVID dataset contains granular demographic and morbidity data, supplemented from primary care records, to add to the understanding of patient factors on disease outcomes.
PIONEER geography The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. There is a higher than average percentage of minority ethnic groups. WM has a large number of elderly residents but is the youngest population in the UK. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. The West Midlands was one of the hardest hit regions for COVID admissions in both wave 1 and 2.
EHR. University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. UHB has cared for >5000 COVID admissions to date.
Scope: All COVID swab confirmed hospitalised patients to UHB from January – May 2020. The dataset includes highly granular patient demographics & co-morbidities taken from ICD-10 & SNOMED-CT codes but also primary care records and clinic letters. Serial, structured data pertaining to care process (timings, staff grades, specialty review, wards), presenting complaint, acuity, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations), all blood results, microbiology, all prescribed & administered treatments (fluids, antibiotics, inotropes, vasopressors, organ support), all outcomes. Linked images available (radiographs, CT, MRI, ultrasound).
Available supplementary data: Health data preceding and following admission event. Matched “non-COVID” controls; ambulance, 111, 999 data, synthetic data.
Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.
Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Reporting of new Aggregate Case and Death Count data was discontinued May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. This dataset will receive a final update on June 1, 2023, to reconcile historical data through May 10, 2023, and will remain publicly available.
Aggregate Data Collection Process Since the start of the COVID-19 pandemic, data have been gathered through a robust process with the following steps:
Methodology Changes Several differences exist between the current, weekly-updated dataset and the archived version:
Confirmed and Probable Counts In this dataset, counts by jurisdiction are not displayed by confirmed or probable status. Instead, confirmed and probable cases and deaths are included in the Total Cases and Total Deaths columns, when available. Not all jurisdictions report probable cases and deaths to CDC.* Confirmed and probable case definition criteria are described here:
Council of State and Territorial Epidemiologists (ymaws.com).
Deaths CDC reports death data on other sections of the website: CDC COVID Data Tracker: Home, CDC COVID Data Tracker: Cases, Deaths, and Testing, and NCHS Provisional Death Counts. Information presented on the COVID Data Tracker pages is based on the same source (total case counts) as the present dataset; however, NCHS Death Counts are based on death certificates that use information reported by physicians, medical examiners, or coroners in the cause-of-death section of each certificate. Data from each of these pages are considered provisional (not complete and pending verification) and are therefore subject to change. Counts from previous weeks are continually revised as more records are received and processed.
Number of Jurisdictions Reporting There are currently 60 public health jurisdictions reporting cases of COVID-19. This includes the 50 states, the District of Columbia, New York City, the U.S. territories of American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, Puerto Rico, and the U.S Virgin Islands as well as three independent countries in compacts of free association with the United States, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. New York State’s reported case and death counts do not include New York City’s counts as they separately report nationally notifiable conditions to CDC.
CDC COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths, available by state and by county. These and other data on COVID-19 are available from multiple public locations, such as:
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
https://www.cdc.gov/covid-data-tracker/index.html
https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/surveillance-data-analytics.html
Additional COVID-19 public use datasets, include line-level (patient-level) data, are available at: https://data.cdc.gov/browse?tags=covid-19.
Archived Data Notes:
November 3, 2022: Due to a reporting cadence issue, case rates for Missouri counties are calculated based on 11 days’ worth of case count data in the Weekly United States COVID-19 Cases and Deaths by State data released on November 3, 2022, instead of the customary 7 days’ worth of data.
November 10, 2022: Due to a reporting cadence change, case rates for Alabama counties are calculated based on 13 days’ worth of case count data in the Weekly United States COVID-19 Cases and Deaths by State data released on November 10, 2022, instead of the customary 7 days’ worth of data.
November 10, 2022: Per the request of the jurisdiction, cases and deaths among non-residents have been removed from all Hawaii county totals throughout the entire time series. Cumulative case and death counts reported by CDC will no longer match Hawaii’s COVID-19 Dashboard, which still includes non-resident cases and deaths.
November 17, 2022: Two new columns, weekly historic cases and weekly historic deaths, were added to this dataset on November 17, 2022. These columns reflect case and death counts that were reported that week but were historical in nature and not reflective of the current burden within the jurisdiction. These historical cases and deaths are not included in the new weekly case and new weekly death columns; however, they are reflected in the cumulative totals provided for each jurisdiction. These data are used to account for artificial increases in case and death totals due to batched reporting of historical data.
December 1, 2022: Due to cadence changes over the Thanksgiving holiday, case rates for all Ohio counties are reported as 0 in the data released on December 1, 2022.
January 5, 2023: Due to North Carolina’s holiday reporting cadence, aggregate case and death data will contain 14 days’ worth of data instead of the customary 7 days. As a result, case and death metrics will appear higher than expected in the January 5, 2023, weekly release.
January 12, 2023: Due to data processing delays, Mississippi’s aggregate case and death data will be reported as 0. As a result, case and death metrics will appear lower than expected in the January 12, 2023, weekly release.
January 19, 2023: Due to a reporting cadence issue, Mississippi’s aggregate case and death data will be calculated based on 14 days’ worth of data instead of the customary 7 days in the January 19, 2023, weekly release.
January 26, 2023: Due to a reporting backlog of historic COVID-19 cases, case rates for two Michigan counties (Livingston and Washtenaw) were higher than expected in the January 19, 2023 weekly release.
January 26, 2023: Due to a backlog of historic COVID-19 cases being reported this week, aggregate case and death counts in Charlotte County and Sarasota County, Florida, will appear higher than expected in the January 26, 2023 weekly release.
January 26, 2023: Due to data processing delays, Mississippi’s aggregate case and death data will be reported as 0 in the weekly release posted on January 26, 2023.
February 2, 2023: As of the data collection deadline, CDC observed an abnormally large increase in aggregate COVID-19 cases and deaths reported for Washington State. In response, totals for new cases and new deaths released on February 2, 2023, have been displayed as zero at the state level until the issue is addressed with state officials. CDC is working with state officials to address the issue.
February 2, 2023: Due to a decrease reported in cumulative case counts by Wyoming, case rates will be reported as 0 in the February 2, 2023, weekly release. CDC is working with state officials to verify the data submitted.
February 16, 2023: Due to data processing delays, Utah’s aggregate case and death data will be reported as 0 in the weekly release posted on February 16, 2023. As a result, case and death metrics will appear lower than expected and should be interpreted with caution.
February 16, 2023: Due to a reporting cadence change, Maine’s
Number of deaths and age-specific mortality rates for selected grouped causes, by age group and sex, 2000 to most recent year.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Datasets in this publication report the number of diagnoses with coronavirus disease (COVID-19) as reported by the Department of Health in Ireland. This includes new cases diagnosed per day and cumulative cases, hospitalisations, ICU admissions, deaths, number of healthcare workers, number of clusters, gender of cases, age groups of cases, mode of transmission, age groups of those hospitalised, and cases per county. To aid standardisation of age groups and cases per county, the population estimates by age group for 2019 and the actual county population in the 2016 Census from Ireland's Central Statistics Office are also included as separate datasets, to allow expression of cases per million population.
These are
age_population_cso_2019.csv has been updated to include separate population estimates for those aged 65-74 years, 75-84 years, and 85 years and over. This is in response to the HSPC releasing case and hospitalisation data for these groups rather than a combined 65 years and over group.
counties_population_cso_2016.csv has been updated to remove trailing spaces in the 'county' column.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Effective September 27, 2023, this dataset will no longer be updated. Similar data are accessible from wonder.cdc.gov.
Deaths involving COVID-19, pneumonia, and influenza reported to NCHS by sex, age group, and jurisdiction of occurrence.